1 citations · 1 across the 1 of their papers we have counts for
1 paper
Cong Chen, Mo Huang, Xuekui Zhang
FDA's Project Optimus initiative for oncology drug development emphasizes selecting a dose that optimizes both efficacy and safety. When an inferentially adaptive Phase 2/3 design…